FDA Inspection 1002305 — Lingraphicare America, Inc.

Lingraphicare America, Inc. — FEI 1000123978

The FDA completed an inspection of Lingraphicare America, Inc. on Feb 15, 2017 in Princeton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 4 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 15, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Princeton, NJ (United States)

Citations

IDCFRDescription
1472221 CFR 820.40Procedures not adequately established or maintained
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
312521 CFR 820.80(d)Lack of or inadequate final acceptance procedures
312721 CFR 820.80(e)Documentation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.